forty-seven children or adolescents with initial stage iv ( 42 patients ) or stage iii ( five ) advanced neuroblastoma ( 12 were progressing after relapse and 35 had never reached complete remission [ cr ] after conventional therapy ) were included in a phase ii study of the combination of high-dose vp-16 ( 100 mg/m2/d x 5 ) and high-dose cisplatin ( cddp ) ( 40 mg/m2/d x 5 ) .
C0027819
neuroblastoma
C0008838
cddp